Advertisement
Screener

Bausch Health Companies Inc. (BHC) Foreign Currency Transaction Gain (Loss), before Tax

1.3 / 5 stars · 23/86 Roast Me

Bausch Health Companies Inc. Foreign Currency Transaction Gain (Loss), before Tax

Bausch Health Companies Inc. (BHC) reported Foreign Currency Transaction Gain (Loss), before Tax of -$7.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Other Income

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-07-30

  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$7.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$11.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$11.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$7.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$52.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$47.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$52.00M.
  • Bausch Health Companies Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$8.00M, a 214.29% decline from fiscal 2021.
Period endForeign Currency Transaction Gain (Loss), before Tax 3 monthForeign Currency Transaction Gain (Loss), before Tax 3 month as first filedForeign Currency Transaction Gain (Loss), before Tax 6 monthForeign Currency Transaction Gain (Loss), before Tax 6 month as first filedForeign Currency Transaction Gain (Loss), before Tax 9 monthForeign Currency Transaction Gain (Loss), before Tax 9 month as first filedForeign Currency Transaction Gain (Loss), before Tax 12 monthForeign Currency Transaction Gain (Loss), before Tax 12 month as first filed
2026-06-30-$7.00M
10-Q · filed 2026-07-30
-$18.00M
10-Q · filed 2026-07-30
-$29.00M
derived: sum of 3 quarters · filed 2026-07-30
-$36.00M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$11.00M
10-Q · filed 2026-04-30
-$22.00M
derived: sum of 2 quarters · filed 2026-04-30
-$29.00M
derived: sum of 3 quarters · filed 2026-04-30
-$59.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31-$11.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$18.00M
derived: sum of 2 quarters · filed 2026-02-19
-$48.00M
derived: sum of 3 quarters · filed 2026-07-30
-$52.00M
10-K · filed 2026-02-19
2025-09-30-$7.00M
10-Q · filed 2025-10-30
-$37.00M
derived: sum of 2 quarters · filed 2026-07-30
-$41.00M
10-Q · filed 2025-10-30
-$62.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$30.00M
10-Q · filed 2026-07-30
-$34.00M
10-Q · filed 2026-07-30
-$55.00M
derived: sum of 3 quarters · filed 2026-07-30
-$55.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$4.00M
10-Q · filed 2026-04-30
-$25.00M
derived: sum of 2 quarters · filed 2026-04-30
-$25.00M
derived: sum of 3 quarters · filed 2026-04-30
-$36.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$21.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$21.00M
derived: sum of 2 quarters · filed 2026-02-19
-$32.00M
derived: sum of 3 quarters · filed 2026-02-19
-$47.00M
10-K · filed 2026-02-19
2024-09-30$0.00
10-Q · filed 2025-10-30
-$11.00M
derived: sum of 2 quarters · filed 2025-10-30
-$26.00M
10-Q · filed 2025-10-30
-$40.00M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30-$11.00M
10-Q · filed 2025-07-31
-$26.00M
10-Q · filed 2025-07-31
-$40.00M
derived: sum of 3 quarters · filed 2026-02-19
-$47.00M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31-$15.00M
10-Q · filed 2025-05-01
-$29.00M
derived: sum of 2 quarters · filed 2026-02-19
-$36.00M
derived: sum of 3 quarters · filed 2026-02-19
-$57.00M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31-$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$21.00M
derived: sum of 2 quarters · filed 2026-02-19
-$42.00M
derived: sum of 3 quarters · filed 2026-02-19
-$52.00M
10-K · filed 2026-02-19
2023-09-30-$7.00M
10-Q · filed 2024-10-31
-$28.00M
derived: sum of 2 quarters · filed 2024-10-31
-$38.00M
10-Q · filed 2024-10-31
-$50.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30-$21.00M
10-Q · filed 2024-08-01
-$31.00M
10-Q · filed 2024-08-01
-$43.00M
derived: sum of 3 quarters · filed 2025-02-20
-$36.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31-$10.00M
10-Q · filed 2024-05-02
-$22.00M
derived: sum of 2 quarters · filed 2025-02-20
-$15.00M
derived: sum of 3 quarters · filed 2025-02-20
-$11.00M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31-$12.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
-$5.00M
derived: sum of 2 quarters · filed 2025-02-20
-$1.00M
derived: sum of 3 quarters · filed 2025-02-20
-$8.00M
10-K · filed 2025-02-20
2022-09-30$7.00M
10-Q · filed 2023-11-02
$11.00M
derived: sum of 2 quarters · filed 2023-11-02
$4.00M
10-Q · filed 2023-11-02
$0.00
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$4.00M
10-Q · filed 2023-08-03
-$3.00M
10-Q · filed 2023-08-03
-$7.00M
derived: sum of 3 quarters · filed 2024-02-22
-$4.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$7.00M
10-Q · filed 2023-05-04
-$11.00M
derived: sum of 2 quarters · filed 2024-02-22
-$8.00M
derived: sum of 3 quarters · filed 2024-02-22
-$1.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$1.00M
derived: sum of 2 quarters · filed 2024-02-22
$6.00M
derived: sum of 3 quarters · filed 2024-02-22
$7.00M
10-K · filed 2024-02-22
2021-09-30$3.00M
10-Q · filed 2022-11-03
$10.00M
derived: sum of 2 quarters · filed 2022-11-03
$11.00M
10-Q · filed 2022-11-03
$7.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$7.00M
10-Q · filed 2022-08-09
$8.00M
10-Q · filed 2022-08-09
$4.00M
derived: sum of 3 quarters · filed 2023-02-23
-$9.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$1.00M
10-Q · filed 2022-05-10
-$3.00M
derived: sum of 2 quarters · filed 2023-02-23
-$16.00M
derived: sum of 3 quarters · filed 2023-02-23
-$16.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
-$17.00M
derived: sum of 2 quarters · filed 2023-02-23
-$17.00M
derived: sum of 3 quarters · filed 2023-02-23
-$30.00M
10-K · filed 2023-02-23
2020-09-30-$13.00M
10-Q · filed 2021-11-02
-$13.00M
derived: sum of 2 quarters · filed 2021-11-02
-$26.00M
10-Q · filed 2021-11-02
-$30.00M
derived: sum of 4 quarters · filed 2022-05-11
2020-06-30$0.00
10-Q · filed 2021-08-03
-$13.00M
10-Q · filed 2021-08-03
-$17.00M
derived: sum of 3 quarters · filed 2022-05-11
-$8.00M
derived: sum of 4 quarters · filed 2022-05-11
2020-03-31-$13.00M
10-Q · filed 2021-05-04
-$17.00M
derived: sum of 2 quarters · filed 2022-05-11
-$8.00M
derived: sum of 3 quarters · filed 2022-05-11
-$5.00M
derived: sum of 4 quarters · filed 2022-05-11
2019-12-31-$4.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11
$5.00M
derived: sum of 2 quarters · filed 2022-05-11
$8.00M
derived: sum of 3 quarters · filed 2022-05-11
$8.00M
8-K · filed 2022-05-11
2019-09-30$9.00M
10-Q · filed 2020-11-03
$12.00M
derived: sum of 2 quarters · filed 2020-11-03
$12.00M
10-Q · filed 2020-11-03
$17.00M
derived: sum of 4 quarters · filed 2021-05-04
2019-06-30$3.00M
10-Q · filed 2020-08-06
$3.00M
10-Q · filed 2020-08-06
$8.00M
derived: sum of 3 quarters · filed 2021-05-04
$8.00M
derived: sum of 4 quarters · filed 2021-05-04
2019-03-31$0.00
10-Q · filed 2020-05-07
$5.00M
derived: sum of 2 quarters · filed 2021-05-04
$5.00M
derived: sum of 3 quarters · filed 2021-05-04
-$4.00M
derived: sum of 4 quarters · filed 2021-05-04
2018-12-31$5.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04
$5.00M
derived: sum of 2 quarters · filed 2021-05-04
-$4.00M
derived: sum of 3 quarters · filed 2021-05-04
$23.00M
8-K · filed 2021-05-04
2018-09-30$0.00
10-Q · filed 2019-11-04
-$9.00M
derived: sum of 2 quarters · filed 2019-11-04
$18.00M
10-Q · filed 2019-11-04
$38.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30-$9.00M
10-Q · filed 2019-08-06
$18.00M
10-Q · filed 2019-08-06
$38.00M
derived: sum of 3 quarters · filed 2020-02-19
$57.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$27.00M
10-Q · filed 2019-05-06
$47.00M
derived: sum of 2 quarters · filed 2020-02-19
$66.00M
derived: sum of 3 quarters · filed 2020-02-19
$105.00M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$20.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$39.00M
derived: sum of 2 quarters · filed 2020-02-19
$78.00M
derived: sum of 3 quarters · filed 2020-02-19
$107.00M
10-K · filed 2020-02-19
2017-09-30$19.00M
10-Q · filed 2018-11-06
$58.00M
derived: sum of 2 quarters · filed 2018-11-06
$87.00M
10-Q · filed 2018-11-06
$42.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30$39.00M
10-Q · filed 2018-08-07
$68.00M
10-Q · filed 2018-08-07
$23.00M
derived: sum of 3 quarters · filed 2019-02-20
$21.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-03-31$29.00M
10-Q · filed 2018-05-08
-$16.00M
derived: sum of 2 quarters · filed 2019-02-20
-$18.00M
derived: sum of 3 quarters · filed 2019-02-20
-$6.00M
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31-$45.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
-$47.00M
derived: sum of 2 quarters · filed 2019-02-20
-$35.00M
derived: sum of 3 quarters · filed 2019-02-20
-$41.00M
10-K · filed 2019-02-20
2016-09-30-$2.00M
10-Q · filed 2017-11-07
-$2.30M
10-Q · filed 2016-11-09
$10.00M
derived: sum of 2 quarters · filed 2017-11-07
$4.00M
10-Q · filed 2017-11-07
$4.60M
10-Q · filed 2016-11-09
$500.00K
derived: sum of 4 quarters · filed 2018-08-10
2016-06-30$12.00M
10-Q · filed 2017-08-08
$13.10M
10-Q · filed 2016-08-09
$6.00M
10-Q · filed 2017-08-08
$6.90M
10-Q · filed 2016-08-09
$2.50M
derived: sum of 3 quarters · filed 2018-08-10
-$31.50M
derived: sum of 4 quarters · filed 2018-08-10
2016-03-31-$6.00M
10-Q · filed 2017-05-09
-$6.20M
10-Q · filed 2016-06-07
-$9.50M
derived: sum of 2 quarters · filed 2018-08-10
-$43.50M
derived: sum of 3 quarters · filed 2018-08-10
-$37.90M
derived: sum of 4 quarters · filed 2018-08-10
2015-12-31-$3.50M
derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10
-$37.50M
derived: sum of 2 quarters · filed 2018-08-10
-$31.90M
derived: sum of 3 quarters · filed 2018-08-10
-$103.00M
8-K · filed 2018-08-10
-$102.80M
10-K · filed 2016-04-29
2015-09-30-$34.00M
10-Q · filed 2016-11-09
-$28.40M
derived: sum of 2 quarters · filed 2016-11-09
-$99.50M
10-Q · filed 2016-11-09
-$180.50M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$5.60M
10-Q · filed 2016-08-09
-$65.50M
10-Q · filed 2016-08-09
-$146.50M
derived: sum of 3 quarters · filed 2017-03-01
-$199.50M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$71.10M
10-Q · filed 2016-06-07
-$152.10M
derived: sum of 2 quarters · filed 2017-03-01
-$205.10M
derived: sum of 3 quarters · filed 2017-03-01
-$201.70M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$81.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$134.00M
derived: sum of 2 quarters · filed 2017-03-01
-$130.60M
derived: sum of 3 quarters · filed 2017-03-01
-$144.00M
10-K · filed 2017-03-01
-$144.10M
10-K · filed 2015-02-25
2014-09-30-$53.00M
10-Q · filed 2015-10-26
-$49.60M
derived: sum of 2 quarters · filed 2015-10-26
-$63.00M
10-Q · filed 2015-10-26
-$68.90M
derived: sum of 4 quarters · filed 2016-04-29
2014-06-30$3.40M
10-Q · filed 2015-07-28
-$10.00M
10-Q · filed 2015-07-28
-$15.90M
derived: sum of 3 quarters · filed 2016-04-29
-$10.80M
derived: sum of 4 quarters · filed 2016-04-29
2014-03-31-$13.40M
10-Q · filed 2015-04-30
-$19.30M
derived: sum of 2 quarters · filed 2016-04-29
-$14.20M
derived: sum of 3 quarters · filed 2016-04-29
-$24.20M
derived: sum of 4 quarters · filed 2016-04-29
2013-12-31-$5.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
-$800.00K
derived: sum of 2 quarters · filed 2016-04-29
-$10.80M
derived: sum of 3 quarters · filed 2016-04-29
-$9.40M
10-K · filed 2016-04-29
-$9.46M
10-K · filed 2014-02-28
2013-09-30$5.10M
10-Q · filed 2014-10-24
$5.08M
10-Q · filed 2013-11-01
-$4.90M
derived: sum of 2 quarters · filed 2014-10-24
-$3.50M
10-Q · filed 2014-10-24
-$3.56M
10-Q · filed 2013-11-01
-$2.26M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30-$10.00M
10-Q · filed 2014-08-01
-$10.08M
10-Q · filed 2013-08-07
-$8.60M
10-Q · filed 2014-08-01
-$8.64M
10-Q · filed 2013-08-07
-$7.36M
derived: sum of 3 quarters · filed 2015-02-25
-$8.96M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$1.40M
10-Q · filed 2014-05-09
$1.44M
10-Q · filed 2013-05-03
$2.64M
derived: sum of 2 quarters · filed 2015-02-25
$1.04M
derived: sum of 3 quarters · filed 2015-02-25
-$3.20M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
-$361.00K
derived: sum of 2 quarters · filed 2015-02-25
-$4.60M
derived: sum of 3 quarters · filed 2015-02-25
$19.70M
10-K · filed 2015-02-25
$19.72M
10-K · filed 2013-02-28
2012-09-30-$1.60M
10-Q · filed 2013-11-01
-$5.84M
derived: sum of 2 quarters · filed 2013-11-01
$18.46M
10-Q · filed 2013-11-01
$44.95M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30-$4.24M
10-Q · filed 2013-08-07
$20.06M
10-Q · filed 2013-08-07
$46.55M
derived: sum of 3 quarters · filed 2014-02-28
$42.96M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$24.30M
10-Q · filed 2013-05-03
$50.79M
derived: sum of 2 quarters · filed 2014-02-28
$47.20M
derived: sum of 3 quarters · filed 2014-02-28
$48.04M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$26.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$22.90M
derived: sum of 2 quarters · filed 2014-02-28
$23.74M
derived: sum of 3 quarters · filed 2014-02-28
$26.55M
10-K · filed 2014-02-28
2011-09-30-$3.59M
10-Q · filed 2012-11-05
-$2.74M
derived: sum of 2 quarters · filed 2012-11-05
$64.00K
10-Q · filed 2012-11-05
$293.00K
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$847.00K
10-Q · filed 2012-08-03
$3.65M
10-Q · filed 2012-08-03
$3.88M
derived: sum of 3 quarters · filed 2013-02-28
$4.18M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$2.81M
10-Q · filed 2012-05-04
$3.04M
derived: sum of 2 quarters · filed 2013-02-28
$3.34M
derived: sum of 3 quarters · filed 2013-02-28
$4.00M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$229.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$530.00K
derived: sum of 2 quarters · filed 2013-02-28
$1.20M
derived: sum of 3 quarters · filed 2013-02-28
$574.00K
10-K · filed 2013-02-28
2010-09-30$301.00K
10-Q · filed 2011-11-04
$968.00K
derived: sum of 2 quarters · filed 2011-11-04
$345.00K
10-Q · filed 2011-11-04
-$66.00K
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30$667.00K
10-Q · filed 2011-08-08
$44.00K
10-Q · filed 2011-08-08
-$367.00K
derived: sum of 3 quarters · filed 2012-02-29
-$170.00K
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31-$623.00K
10-Q · filed 2011-05-10
-$1.03M
derived: sum of 2 quarters · filed 2012-02-29
-$837.00K
derived: sum of 3 quarters · filed 2012-02-29
-$523.00K
derived: sum of 4 quarters · filed 2012-02-29
2009-12-31-$411.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
-$214.00K
derived: sum of 2 quarters · filed 2012-02-29
$100.00K
derived: sum of 3 quarters · filed 2012-02-29
$507.00K
10-K · filed 2012-02-29
2009-09-30$197.00K
10-Q · filed 2010-11-05
$511.00K
derived: sum of 2 quarters · filed 2010-11-05
$918.00K
10-Q · filed 2010-11-05
2009-06-30$314.00K
10-Q · filed 2010-08-06
$721.00K
10-Q · filed 2010-08-06
2008-12-31-$1.06M
10-K · filed 2011-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42